Ratings by Rothschild Redburn (Ed Ridley-Day)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2026 | Abbott Labs | ABT | Upgrade | Buy (Neutral) |
98.83 (98.39) |
-0.45% | Details | |
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Neutral (N/A) |
41.25 (35.43) |
-14.11% | Details | |
| 10/8/2025 | Danaher | DHR | Downgrade | Neutral (Buy) |
211.71 (217.49) |
2.73% | Details | |
| 9/18/2025 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
99.12 (90.25) |
-8.95% | Details | |
| 9/18/2025 | Stryker | SYK | New Coverage | Neutral (N/A) |
376.62 (279.46) |
-25.8% | Details | |
| 9/3/2024 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
104.81 (100.00) |
-4.59% | Details | |
| 8/2/2024 | Intuitive Surgical | ISRG | Upgrade | Buy (Neutral) |
444.61 (405.27) |
-8.85% | Details |
